Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001104659-21-123124
Filing Date
2021-10-05
Accepted
2021-10-05 16:23:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 POS AM tm2127087d4_posam.htm POS AM 23990
  Complete submission text file 0001104659-21-123124.txt   25020
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

EIN.: 981130690 | State of Incorp.: L2
Type: POS AM | Act: 33 | File No.: 333-223575 | Film No.: 211306935
SIC: 2834 Pharmaceutical Preparations